Management of respiratory pseudomonal infections in cystic fibrosis: Many strategies to consider

Drugs and Therapy Perspectives

Volumn 17, Issue 18, 2001, Pages 5-9

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZLOCILLIN; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; MONOBACTAM; PENICILLIN DERIVATIVE; PIPERACILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; TAZOBACTAM; TICARCILLIN; TOBRAMYCIN;

ACUTE DISEASE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BURKHOLDERIA CEPACIA; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS INFECTION; CYSTIC FIBROSIS; DISEASE EXACERBATION; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HOME CARE; HOSPITAL CARE; HUMAN; LUNG FUNCTION; MONOTHERAPY; NEBULIZER; NEPHROTOXICITY; OTOTOXICITY; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION;

EID: 0035840059     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-200117180-00002     Document Type: Article

References (15)

1. The treatment of respiratory Pseudomonas infection in cystic fibrosis. What drug and which way?
2. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, perfloxacin, sparfloxacin and trovafloxacin against Gram-positive and Gram-negative pathogens from respiratory tract infections
3. Intermittent ciprofloxacin in adults with cystic fibrosis and chronic Pseudomonas pulmonary infection
4. Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis
5. Comparison of beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis
6. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections
7. Four years' experience of intravenous colomycin in an adult cystic fibrosis unit
8. Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection
9. Inhalation of antibiotics in cystic fibrosis
10. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
11. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis
12. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995)
13. Home intravenous antibiotics for cystic fibrosis
14. Home intravenous therapy in cystic fibrosis: A prospective randomized trial examining clinical, quality of life and cost aspects